Xeris Biopharma Holdings Inc. buy Piper Sandler
Start price
10.05.24
/
50%
€1.64
Target price
10.05.25
€2.78
Performance (%)
188.96%
End price
11.05.25
€4.74
Summary
This prediction ended on 11.05.25 with a price of €4.74. The BUY prediction by Piper_Sandler for Xeris Biopharma Holdings Inc. saw massive gains of 188.96%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Xeris Biopharma Holdings Inc. | -1.497% | -1.497% | 45.382% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
Comments by Piper_Sandler for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
Ratings data for XERS provided by MarketBeat
In the thread Trading Xeris Biopharma Holdings Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Piper_Sandler for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€1.60
10.11.23
10.11.23
€3.74
10.11.24
10.11.24
99.88%
11.11.24
11.11.24
